SCHEMBL20164377

SCHEMBL20164377

CNc1nc(NCC(O)CO)nc2c(NC)nc(Cl)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 5/20 0.41
CDK2 P24941 4/20 0.36
CCNE1 P24864 3/20 0.36
CDK5 Q00535 2/20 0.36
CCNE2 O96020 2/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
IDH2 P48735 3/20 0.34
YTHDF3 Q7Z739 2/20 0.34
YTHDF1 Q9BYJ9 2/20 0.34
YTHDF2 Q9Y5A9 2/20 0.34
SLC29A1 Q99808 1/20 0.33
MAPK14 Q16539 1/20 0.33
CCNT1 O60563 1/20 0.33
CCNA2 P20248 1/20 0.33
CSNK1A1 P48729 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
CDK9 P50750 1/20 0.33
CCNA1 P78396 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30560025 1.00 YTHDC1 (0.41) YTHDC1CDK2CCNE1CDK5CCNE2
SCHEMBL20164425 0.89 YTHDC1 (0.38) YTHDC1LMNASMN1; SMN2YTHDF3YTHDF1
SCHEMBL30560041 0.85 YTHDC1 (0.40) YTHDC1CDK2CCNE1CDK5LMNA
SCHEMBL20164331 0.85 YTHDC1 (0.40) YTHDC1CDK2CCNE1CDK5LMNA
SCHEMBL20164544 0.85 YTHDC1 (0.40) YTHDC1CDK2CCNE1CDK5LMNA
SCHEMBL20164329 0.85 YTHDC1 (0.40) YTHDC1CDK2CCNE1CDK5LMNA
SCHEMBL20164702 0.83 SLC29A1 (0.46) CDK2CCNE1CDK5CCNE2LMNA
SCHEMBL20179426 0.83 SLC29A1 (0.46) CDK2CCNE1CDK5CCNE2LMNA
Hydrochloric Acid SCHEMBL20164336 0.82 SLC29A1 (0.44) CDK2CCNE1CDK5CCNE2LMNA
SCHEMBL7937474 0.81 SLC29A1 (0.35) YTHDC1CDK2CCNE1CCNE2IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3316890-B1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF MAKING AND USING SAME NEURAD LTD (IL) 2023-09-06 EP disclosed
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same NEURAD LTD. (IL) 2019-05-21 US disclosed
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same NEURAD LTD. (IL) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141953-A1 Novel Breathing Control Modulating Compounds, and Methods of Making and Using Same MTNR1B, CHRM3, PER2 YTHDC1 2024/4885CDK2 4026/4885CCNE1 4167/4885
US-10294228-B2 Breathing control modulating compounds, and methods of making and using same MTNR1B, PDE3A, CHRM3 YTHDC1 2085/4885CDK2 4190/4885CCNE1 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.